| Dr Heather Mccall Webb, OD | |
|
630 Colonial Promenade Pkwy, Alabaster, AL 35007-3111 | |
| (205) 663-2169 | |
| (205) 663-2217 |
| Full Name | Dr Heather Mccall Webb |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 28 Years |
| Location | 630 Colonial Promenade Pkwy, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205939485 | NPI | - | NPPES |
| 51529924 | Other | AL | BCBS OF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S-837 TA-362 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J And H Webb, Inc. | 1951292630 | 2 |
News Archive
Catherine Ashton, High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission, and Kristalina Georgieva, Commissioner for Humanitarian Aid and Civil Protection, will visit Haiti to evaluate the development of European humanitarian aid and assess future needs.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Diabetes has reached epidemic proportions in Asia and has dramatically increased the risk of premature death, especially among women and middle-aged people, a multinational study led by Vanderbilt University researchers has found.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
› Verified 1 days ago
| Provider Name | J And H Webb, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336332774 PECOS PAC ID: 1951292630 Enrollment ID: O20040323000165 |
News Archive
Catherine Ashton, High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission, and Kristalina Georgieva, Commissioner for Humanitarian Aid and Civil Protection, will visit Haiti to evaluate the development of European humanitarian aid and assess future needs.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Diabetes has reached epidemic proportions in Asia and has dramatically increased the risk of premature death, especially among women and middle-aged people, a multinational study led by Vanderbilt University researchers has found.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather Mccall Webb, OD 700 Old Cahaba Dr, Helena, AL 35080-7043 Ph: (205) 621-0164 | Dr Heather Mccall Webb, OD 630 Colonial Promenade Pkwy, Alabaster, AL 35007-3111 Ph: (205) 663-2169 |
News Archive
Catherine Ashton, High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission, and Kristalina Georgieva, Commissioner for Humanitarian Aid and Civil Protection, will visit Haiti to evaluate the development of European humanitarian aid and assess future needs.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Diabetes has reached epidemic proportions in Asia and has dramatically increased the risk of premature death, especially among women and middle-aged people, a multinational study led by Vanderbilt University researchers has found.
The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
› Verified 1 days ago
Dr. James Wesley Webb, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 630 Colonial Promenade Pkwy, Alabaster, AL 35007 Phone: 205-620-4697 Fax: 205-663-2217 | |
Alabaster Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 9200 Highway 119, Suite 600, Alabaster, AL 35007 Phone: 205-447-9379 | |
Dr. James Andrew Ho, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 1st St N, Alabaster, AL 35007 Phone: 205-949-2020 | |
Dr. Erin Raynaud Heckman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1136 1st St N, Alabaster, AL 35007 Phone: 205-624-2500 Fax: 205-624-2502 | |
Melanie Chwalek, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 1st St N, Alabaster, AL 35007 Phone: 205-949-2020 Fax: 205-663-2015 | |
Shelby Family Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1136 1st St N, Alabaster, AL 35007 Phone: 205-624-2500 Fax: 205-624-2502 |